Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEEWC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,642
Award facts
- Contract value 100% obligated
- $40,641.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $40,641.87 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen injections on July 14, 2025, with completion expected by July 15, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat various inflammatory and autoimmune conditions, reflecting the company's established role as a primary pharmaceutical supplier for military and federal healthcare systems.
This delivery order is a child contract under AmerisourceBergen's $999.9 billion Pharmaceutical Prime Vendor Global Program IDC with DLA Troop Support Medical, which operates through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The company's substantial indefinite delivery contract enables it to supply specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's consistent success in winning competitive federal pharmaceutical awards demonstrates its capability to meet stringent federal procurement standards and supply chain requirements for critical medical commodities supporting military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FEEWC?
SPE2DB25FEEWC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FEEWC worth?
The government has obligated $40,642 on SPE2DB25FEEWC.
Is contract SPE2DB25FEEWC an order under another contract?
Yes. SPE2DB25FEEWC is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEEWC competed?
The extent of competition for SPE2DB25FEEWC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award